Literature DB >> 28272138

Intolerance of dolutegravir-containing combination antiretroviral therapy: not just a pharmacokinetic drug interaction.

Dario Cattaneo1, Giuliano Rizzardini, Cristina Gervasoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28272138     DOI： 10.1097/QAD.0000000000001394

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  2 in total

1.  Virologic Failure Among People Living With HIV Initiating Dolutegravir-Based Versus Other Recommended Regimens in Real-World Clinical Care Settings.

Authors:  Robin M Nance; Vani Vannappagari; Kimberly Smith; Catherine B Johannes; Brian Calingaert; Catherine W Saltus; Kenneth H Mayer; Bridget M Whitney; Benigno Rodriguez; Richard D Moore; Joseph J Eron; Elvin Geng; William Christopher Mathews; Michael J Mugavero; Michael S Saag; Mari M Kitahata; Joseph A C Delaney; Heidi M Crane
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-15       Impact factor: 3.731

2.  Impact of UGT1A1 gene polymorphisms on plasma dolutegravir trough concentrations and neuropsychiatric adverse events in Japanese individuals infected with HIV-1.

Authors:  Hiroki Yagura; Dai Watanabe; Hiroyuki Kushida; Kosuke Tomishima; Hiroaki Togami; Atsushi Hirano; Masaaki Takahashi; Kazuyuki Hirota; Motoko Ikuma; Daisuke Kasai; Yasuharu Nishida; Munehiro Yoshino; Kunio Yamazaki; Tomoko Uehira; Takuma Shirasaka
Journal:  BMC Infect Dis       Date:  2017-09-16       Impact factor: 3.090
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.